Volumetric-modulated arc therapy for a pelvic lymph node metastasis from prostate cancer: A case report - Abstract

A 50-year-old patient had an early biochemical recurrence after radical prostatectomy and androgen deprivation therapy and castration. An anti-1-amino-3-[18F] fluorocyclobutane-1-carboxylic acid positron emission tomography/computed tomography scan showed a single pelvic lymph node metastasis. The patient was given volume-modulated arc therapy with a cumulative dose of 50 Gy for the volume with pelvic lymph nodes and 78 Gy to the boost volume for the lymph node metastasis. He experienced only a transitory mild toxicity from the rectum and the urinary bladder and had a partial remission for 16 months.

Written by:
von Eyben FE, Kangasmäki A, Kiljunen T, Joensuu T.   Are you the author?
Center for Tobacco Control, Odense, Denmark; International Comprehensive Cancer Center Docrates, Helsinki, Finland.

Reference: Tumori. 2013 May-Jun;99(3):120e-3e.
doi: 10.1700/1334.14819Tumori 2013;99(3):e120-e123


PubMed Abstract
PMID: 24158080

Go "Beyond the Abstract" - Read an article written by the authors for UroToday.com

UroToday.com Prostate Cancer Section